Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Healthcare Copper
Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Medivolve Inc > New Platfrom to deliver BLOWFISH results
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1060)
•••
Comment by Hiddensecretson May 06, 2021 9:19am
74 Views
Post# 33139493

RE:RE:New Platfrom to deliver BLOWFISH results

RE:RE:New Platfrom to deliver BLOWFISH resultsMEDV will recover the cost of the platform by charging each client around the world a fee, say $ 9.99 per year. 

And the platform would be used for covi19, adxit, blowfish, telehealth, etc....

Even if Marvel walked away, MEDV would still get 42% of its revenue around the world. 

You cannot grow if you always act with DOUBT and FEAR.    Imagine MEDV telling Marvel, we do not trust you and, refuse to acquire a platform.   Is this the message they are to give to them?   Marvel would then say, then why did you acquire 42%?

Instead MEDV invests in the platform showing that they trust them and are serious about GROWTH. 

This was the next logicial step in becoming a TELEDIAGNOSTIC company, you needed a platform of some sort for the medical / patient industry.   Each company that operates in this industry has their own. 

MPO


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities